A report from the Ongoing Tirofiban In Myocardial Infarction Evaluation (On-TIME 2) investigators demonstrates that patients with ST-segment elevation myocardial infarction (STEMI) benefit from ...

The tirofiban hydrochloride HPLC method, previously described by Merck Research Laboratories, [5] was modified (flow rate increased from 1.0 to 1.5 mL/min, run time shortened, and column ...